Improving Patient Reported Outcome Measures in Catheter Ablation

Launched by BARTS & THE LONDON NHS TRUST · Jul 31, 2020

Keywords

ClinConnect Summary

This clinical trial is looking at how often patients report their health-related quality of life (HRQL) after undergoing a procedure called catheter ablation for a heart condition known as ventricular tachycardia (VT). The goal is to see if checking in more frequently with patients about their well-being can help doctors better understand how effective and cost-efficient this treatment is for people who have an Implantable Cardioverter Defibrillator (ICD) implanted in their chest.

To participate in this study, you need to be an adult over 18 years old who has had an ICD for at least three months and has experienced a documented episode of VT that required treatment. You should also be willing to provide informed consent, meaning you understand what the study involves. Participants can expect to complete assessments about their quality of life, which will help researchers gather important information on the impact of the treatment. This study is currently recruiting participants of all genders, and it is important to note that those planning to move away from the study site within a year or who cannot provide informed consent are not eligible to join.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults (\>18 years) With an Implantable Cardioverter Defibrillator (ICD) implanted \>3 months from time of recruitment and a previous episode of documented VT requiring therapy from the ICD.
• • And impaired LV/RV function Willing and able to give written informed consent
• Exclusion Criteria:
• • Patients who are planning to move away from study site within 12 months of enrolment who wished to use postal method to complete their HRQL Patients who are unable to give informed consent